Influenza A virus is a human pathogen with a genome composed of eight viral RNA segments that replicate in the nucleus. Two viral mRNAs are alternatively spliced. The unspliced M1 mRNA is translated into the matrix M1 protein, while the ion channel M2 protein is generated after alternative splicing. These proteins are critical mediators of viral trafficking and budding. We show that the influenza virus uses nuclear speckles to promote post-transcriptional splicing of its M1 mRNA. We assign previously unknown roles for the viral NS1 protein and cellular factors to an intranuclear trafficking pathway that targets the viral M1 mRNA to nuclear speckles, mediates splicing at these nuclear bodies and exports the spliced M2 mRNA from the nucleus. Given that nuclear speckles are storage sites for splicing factors, which leave these sites to splice cellular pre-mRNAs at transcribing genes, we reveal a functional subversion of nuclear speckles to promote viral gene expression.
Influenza A virus is a human pathogen with a genome composed of eight viral RNA segments that replicate in the nucleus. Two viral mRNAs are alternatively spliced. The unspliced M1 mRNA is translated into the matrix M1 protein, while the ion channel M2 protein is generated after alternative splicing. These proteins are critical mediators of viral trafficking and budding. We show that the influenza virus uses nuclear speckles to promote post-transcriptional splicing of its M1 mRNA. We assign previously unknown roles for the viral NS1 protein and cellular factors to an intranuclear trafficking pathway that targets the viral M1 mRNA to nuclear speckles, mediates splicing at these nuclear bodies and exports the spliced M2 mRNA from the nucleus. Given that nuclear speckles are storage sites for splicing factors, which leave these sites to splice cellular pre-mRNAs at transcribing genes, we reveal a functional subversion of nuclear speckles to promote viral gene expression.
M ammalian nuclei contain ∼20-50 speckles of varying size, which are also known as interchromatin granule clusters (IGCs). These nuclear bodies are involved in the maturation and storage of pre-mRNA splicing factors, RNA processing factors, transcription factors and other factors that function in gene expression [1] [2] [3] . It has been shown that splicing factors leave nuclear speckles to function at active transcribing genes in the nucleoplasm, demonstrating the dynamic nature of this compartment 4 . Thus, most gene transcription and splicing does not occur at nuclear speckles 5 . Although controversial, it has been reported that posttranscription splicing may be spatially mediated at nuclear speckles 6 . This concept is supported by the accumulation of specific polyadenylated mRNAs (including mRNA originating from plasmid) at nuclear speckles, which appear to be involved in splicing and/or exporting these mRNAs to the cytoplasm [7] [8] [9] [10] . However, most cellular pre-mRNAs do not use nuclear speckles, which instead serve as suppliers of factors with key roles in gene expression 1 .
Viruses such as influenza viruses usurp cellular factors to execute splicing of viral mRNAs 11 . Two influenza virus mRNAs, NS1 and M1, are alternatively spliced 11 . The unspliced NS1 and M1 mRNAs are translated into non-structural 1 (NS1) and M1 proteins, respectively, while the nuclear export protein (NEP, also known as NS2) and M2 mRNAs are generated after splicing. Other alternative spliced forms of M1 mRNA have been detected and include mRNA 3 , which is not known to encode a peptide 12, 13 , and M4 mRNA, which encodes an isoform of the M2 ion channel and is only present in certain viral strains 11, 14, 15 . NS1, NS2, M1 and M2 proteins have critical functions during the virus life cycle, so the mechanisms involved in influenza virus mRNA alternative splicing represent key steps in the viral life cycle. However, the processes involved in viral mRNA splicing have not been fully elucidated.
Results
Influenza virus M mRNA accumulates at nuclear speckles. To spatially and temporally define the mechanisms involved in influenza virus M1 mRNA alternative splicing and export, we first followed M1 mRNA distribution using single-molecule RNAfluorescence in situ hybridization (smFISH) in infected cells. Forty-six FISH probes covering the entire M1 mRNA of the influenza A/WSN/33 virus strain were generated to detect single M1 mRNA transcripts during influenza virus infection ( Fig. 1a and Supplementary Section 'Fluorescence in situ hybridization (FISH) probes', M mRNA probes). Although these 46 probes can recognize M1 and its alternative spliced forms, they can only detect M1 at the single-molecule level due to the small size of the other spliced forms that are recognized in bulk. Hence, we label the signal detected with the 46 probes as M mRNA. At 3 h after infection we observed that single M1 mRNA transcripts are detected in the nucleus and in the cytoplasm, indicating efficient transcription and nuclear export of M1 mRNA (Fig. 1b) . Notably, M mRNA accumulates significantly at intranuclear foci ∼4-5 h post-infection (Fig. 1b) . RNA-FISH and immunofluorescence staining against M mRNA and SC35 protein, respectively, showed that M mRNA is enriched at nuclear speckles ( Fig. 1c and Supplementary Movie 1), because SC35 is an SR protein, a known splicing factor and a nuclear speckle marker 1 . Other influenza A virus strains, A/Texas/36/91 and A/Puerto Rico/8/34, also show M mRNA localization at nuclear speckles ( Supplementary  Fig. 1a,b) . Approximately 6 h post-infection, M mRNA enrichment at nuclear speckles is reduced, and most of the M mRNA is detected in the cytoplasm, indicating efficient nuclear export (Fig. 1b,d) .
To determine the number of viral M mRNA molecules at nuclear speckles, we first quantified the fluorescence signal emerging from single mRNA molecules that could be detected in the cytoplasm (Fig. 1e) . In the same cells, we used SC35 labelling to locate nuclear speckles and quantify the overall intensities of RNA-FISH labelled M mRNAs inside the nuclear speckle volume (Fig. 1e) . The M mRNA fluorescent signal at individual speckles was then divided by the average intensity of a single M1 mRNA. In general, nuclear speckles vary in size, ranging from one to several micrometres in diameter 1 . We detected and analysed 682 SC35 labelled nuclear speckles in 16 cells (average of 42.6 nuclear speckles per nucleus) and measured the volume of these nuclear speckles. We found that the average volume of a single nuclear speckle is 0.82 µm 3 (diameter = 1.16 µm). We then calculated the accumulation of Nuclear speckle  Nuclear speckle  detection   0   10   20   30   40   50   60   70   80   90   100  130  120  110  100  90  80  70  60  50  40  30  20  10  0  0  1  2  3  4  5 Values are percentage means ± s.d. of at least 99 cells that were counted in three independent experiments for each time point. p.i., post infection. e, M mRNA quantification at nuclear speckles. Fluorescent signal emerging from labelled M mRNA transcripts was detected in the cytoplasm (single M mRNA detection, white dots) while the M mRNA signal emerging from the nucleus was masked based on Hoechst staining. Nuclear speckles were also marked (nuclear speckle detection, yellow punctate). Images are representative of three independent experiments. Scale bar, 10 µm. f, Quantification of M mRNA copy number at nuclear speckles marked with SC35 antibody. M mRNA fluorescence intensity sum inside speckles was divided by the average intensity sum of individual cytoplasmic M mRNA transcripts. Cells were infected for 4 h and RNA-FISH was quantified as in e. The number of M mRNA at nuclear speckles was plotted according to the nuclear speckle volume. Dotted lines in the graph indicate the average nuclear speckle volume and the corresponding M mRNA copy number. A total of 682 nuclear speckles were analysed in 16 cells.
M mRNAs with respect to the nuclear speckle volume (Fig. 1f ) . We show that there is a linear correlation between nuclear speckle volume and the number of M mRNAs enriched at nuclear speckles (R 2 = 0.869). We also found that inside the average sized nuclear speckle, the bulk M mRNA signal is equivalent to ∼13 M1 mRNA molecules. Thus, we estimate that hundreds of viral M mRNA transcripts enter/pass through nuclear speckles during infection.
We next tested whether the viral NS mRNA, which is also alternatively spliced, accumulates inside nuclear speckles. For this purpose we generated an additional set of probes covering the entire NS mRNA. We then followed both NS mRNA and M1 mRNA (see below for a description of the specific M1 mRNA probes) distribution during infection. At 3 h post-infection, most of the NS mRNA had already been exported to the cytoplasm, while the M1 mRNA was mainly in the nucleus ( Supplementary  Fig. 1c) . In contrast to M1 mRNA, NS mRNA was not enriched at nuclear speckles ( Supplementary Fig. 1c ). This may indicate a major difference between M and NS mRNA biogenesis pathways and that M mRNA specifically uses nuclear speckles for RNA processing.
M mRNA is post-transcriptionally spliced at nuclear speckles. To investigate whether the viral M1 mRNA is actively spliced at nuclear speckles, we generated M1 and M2 probes that specifically label the unspliced M1 mRNA and the spliced M2 mRNA, respectively ( Fig. 2a and Supplementary Fig. 2a-e) . We then monitored both M1 and M2 mRNAs at 4 h post-infection and found that significant pools of both mRNAs were localized at nuclear speckles (Fig. 2b,c) . M1 mRNA also co-localized with U5 snRNA and Prp8 at nuclear speckles, indicating accumulations at speckles that contain high concentrations of key catalytic components of the splicing reaction (Fig. 2d) 16 . In addition, we were also able to detect mRNA 3 at nuclear speckles ( Supplementary Fig. 2f-h ), demonstrating the presence of another spliced product of M1 mRNA at this nuclear body. Thus, the presence of both M1 mRNA and the spliced M2 mRNA and mRNA 3 at nuclear speckles suggests that splicing of the M1 mRNA may occur at nuclear speckles. To reveal whether viral M1 mRNA splicing occurs co-or post-transcriptionally at nuclear speckles, we co-labelled single M vRNA segments using RNA-FISH and tracked accumulation in SC35 marked speckles. At 4 h postinfection, when M mRNAs are enriched at nuclear speckles, we did not detect single M vRNAs at nuclear speckles, but they can be adjacent to these nuclear bodies (Fig. 2e-g ). In fact, comparative imaging analysis of the M vRNA channel and the speckle channel gave a low Pearson's coefficient of 0.17. These findings suggest that the M1 mRNA is first generated upon M vRNA transcription in the nucleoplasm, and M1 mRNA then associates with nuclear speckles for post-transcriptional splicing.
NS1 protein promotes M mRNA splicing and nuclear export via nuclear speckles. M1 mRNA splicing has been linked to the viral NS1 protein 17 and M1 mRNA can interact with NS1 [17] [18] [19] . Additionally, NS1 has been shown to alter the SC35 punctate pattern, suggesting that NS1 may induce changes in nuclear speckle structure and function 20 . Hence, we tested whether NS1 is involved in M mRNA localization and splicing at nuclear speckles using an influenza virus strain that lacks NS1 (WSN ΔNS1) 21 . These infection studies were performed both in Vero cells, which are interferon-deficient and therefore allow replication of this mutant virus, and in A549 cells, which are immune-competent. We found that the lack of NS1 protein significantly reduced the accumulation of M mRNA at nuclear speckles (Fig. 3a,b and Supplementary Fig. 3a-c) and diminished M1 mRNA splicing (Fig. 3c,d and Supplementary Fig. 3d ) in both cell types. Furthermore, after 6 h post-infection, we observed a decrease in M mRNA nuclear export in cells infected with WSN ΔNS1 (Fig. 3e,f and Supplementary Fig. 3e,f ) . Consequently, these effects contribute to the decrease in M1 and M2 protein levels in cells infected with virus lacking NS1 as compared to cells infected with wild-type virus ( Supplementary Fig. 3g-i) . These results point to a specific and previously unknown function of NS1 in promoting M1 mRNA localization at nuclear speckles, which leads to M1 to M2 splicing. This function of NS1 seems to be independent of its inhibitory role of interferon expression, because M mRNA mislocalization and splicing-export defects observed upon WSN ΔNS1 infection occurred in both A549 and Vero cells.
Cellular NS1-BP, hnRNP K and SON proteins mediate M1 mRNA processing at nuclear speckles. We have previously shown that the cellular protein NS1-BP, which interacts with the viral NS1 protein 22 , forms a complex with the cellular hnRNP K protein, and they are required for proper M1 mRNA splicing into M2 mRNA (ref. 23 ). NS1-BP and hnRNP K are RNA binding proteins involved in viral RNA splicing, and the latter has also been linked to cellular pre-mRNA splicing [24] [25] [26] [27] . Thus, we tested whether NS1-BP and hnRNP K have a role in M mRNA localization at nuclear speckles. First, we show that a pool of both NS1-BP and hnRNP K is found at nuclear speckles ( Supplementary  Fig. 4a ). NS1-BP has previously been found at nuclear speckles 22 . In NS1-BP depleted cells, M mRNA accumulation at nuclear speckles was reduced after 4 h post-infection, but the cytoplasmic to nuclear M mRNA ratio, C/N, was not altered ( Supplementary  Fig. 4b ,d-f ). At 6 h post-infection, we observed an inhibition of M mRNA nuclear export in cells depleted of NS1-BP (Fig. 4a,b) . The observed M mRNA mislocalization shown here and the splicing defects we reported following NS1-BP knockdown 23 are similar to those observed in cells infected with WSN ΔNS1 (Fig. 3 and Supplementary Fig. 3a-f ). These data suggest that NS1 and NS1-BP may function together to recruit M1 mRNA to nuclear speckles for splicing, and support the concept that M1 mRNA that is generated at 4-6 h post-infection is not efficiently exported without being processed at nuclear speckles.
We then depleted hnRNP K, which interacts with NS1-BP (ref. 23) . In contrast to NS1-BP depletion, and similar to control cells, hnRNP K depleted cells efficiently accumulated M mRNA at nuclear speckles 4 h post-infection ( Supplementary Fig. 4c-e) . However, at 6 h post-infection we found a significant enrichment of M mRNA at nuclear speckles in hnRNP K depleted cells (Fig. 4a ,c) whereas most of M mRNA is not present at nuclear speckles during this time in the control infected cells, as it has already been exported to the cytoplasm (Fig. 4a-c) . Because M mRNA enters and accumulates at speckles for a prolonged time in hnRNP K knockdown cells, but does not efficiently splice 23 , hnRNP K appears to function on M1 to M2 mRNA splicing at nuclear speckles. Although M mRNA accumulation at nuclear speckles following hnRNP K knockdown is prolonged, the nucleoplasmic M mRNA pool was not enriched, so the C/N ratio of M mRNA was not significantly altered relative to control cells (Fig. 4a,b) . In hnRNP K and NS1-BP knockdown cells, the mislocalization phenotypes may be specific to the viral M mRNA, as cellular GAPDH mRNA localization remained unchanged after NS1-BP and hnRNP K depletion ( Supplementary Fig. 4g ).
To further determine the importance of nuclear speckles for M1 to M2 splicing and export, we perturbed the nuclear speckle structure by knocking down the SON protein. SON was shown to be a scaffold/structural nuclear speckle factor, and its depletion leads to the dispersion of splicing factors from nuclear speckles to the nucleoplasm 28, 29 . SON has also been shown to regulate cell cycle progression, development and disease 28, 29 . In control cells where SON is not depleted, we found that most of the M mRNA is in the cytoplasm at 6 h post-infection (Fig. 4d,e) . In contrast, in SON depleted cells the M mRNA is accumulated at nuclear speckles that contain low levels of SON (Fig. 4d) , while the distribution of GAPDH mRNA remains unchanged ( Supplementary Fig. 4h ). Although some M mRNA was detected in the cytoplasm of SON depleted cells, the C/N ratio of M mRNA was significantly reduced (Fig. 4e) , indicating a defect in M mRNA nuclear export in these cells. SON knockdown also reduced the M2/M1 mRNA ratio during infection (Fig. 4f ) . As a result, SON depletion reduced virus replication as compared to control cells (Fig. 4g ). This effect is consistent with a previous screen that identified SON as an essential cellular protein for influenza virus replication 30 . Together, these findings reveal a novel role for the SON protein in the influenza virus life cycle, supporting the concept of M1 mRNA splicing at nuclear speckles.
TREX components couple viral M mRNA nuclear export to splicing via nuclear speckles. There is some evidence that the TREX components UAP56 and Aly/REF proteins are involved in the release of certain cellular mRNAs from nuclear speckles 7 . In the model of mRNA nuclear export, UAP56 is recruited to the nascent transcript and in turn recruits Aly/REF. Fig. 5a ) and UAP56 has been previously localized at these nuclear bodies 32 . Additionally, Aly/REF and UAP56 have been shown to be involved in nuclear export of M1 and M2 mRNAs (ref. 33 ). We thus tested whether depletion of these factors would lead to a change in M mRNA localization or splicing. By monitoring M1 and M2 mRNA, we found that in both Aly/REF and UAP56 siRNA treated cells, M1 and M2 mRNA accumulate at nuclear speckles and in the nucleoplasm after 6 h, in contrast to control in both A549 and VERO cells (Fig. 5a-d, Supplementary Fig. 5b,c, Fig. 6a and Supplementary Fig. 6) . Surprisingly, RT-qPCR analysis of the M2/M1 mRNA ratio revealed that M1 mRNA splicing was significantly enhanced by the Aly/REF and UAP56 knockdown (Fig. 5e ). Despite this splicing enhancement, both M1 and M2 mRNAs were significantly blocked in the nucleus upon depletion of Aly/REF and UAP56, which resulted in low levels of M1 and M2 proteins (Supplementary Fig. 5d ). Thus, M1 mRNA nuclear export block seems to prolong the accumulation of M1 mRNA at nuclear speckles, which is likely to enhance M1 mRNA splicing.
We next inhibited splicing of M mRNA to determine whether this perturbation would affect its nuclear speckle localization. We used the splicing inhibitor meayamycin, which binds SF3b and therefore prevents the formation of the protein-RNA complexes essential for early spliceosome assembly 34 . M mRNA localization was assessed by RNA-FISH in the absence or presence of this chemical probe. In agreement with previous findings, meayamycin, like its analogue spliceostatin A, increased nuclear speckle sizes (Fig. 5f,g and Supplementary Fig. 5f ) 35 . Additionally, we found that meayamycin treatment promotes premature nuclear export of M mRNA (Fig. 5f ) in addition to inhibiting M1 to M2 splicing ( Supplementary Fig. 2d,e) . To prevent this premature nuclear export effect and still inhibit M mRNA splicing, we took advantage of the Aly/REF phenotype, which inhibits M mRNA nuclear export and increases both the accumulation of M mRNA at nuclear speckles and splicing (Fig. 5a-e and Fig. 5g control) and treated cells with both Aly/REF siRNA and meayamycin ( Fig. 5g and Supplementary Fig. 5e ). We found that meayamycin treatment prevents M mRNA nuclear speckle accumulation and splicing, even in Aly/REF depleted cells that contain high levels of nuclear M1 mRNA (Fig. 5g,h and Supplementary Fig. 5e ). When meayamycin was removed from the medium, M2 mRNA could again be detected after an additional 4 h (Supplementary Fig. 5e ). Examination of both M1 and M2 mRNA distribution by RNA-FISH revealed that M1 and M2 mRNA speckle localization was restored upon meayamycin removal (Supplementary Fig. 5f ). These results indicate that the accumulation of M1 mRNA at nuclear speckles is not a random process but rather a mechanism to induce M1 mRNA splicing.
We next examined the effect of Aly/REF and UAP56 depletion during WSN ΔNS1 virus infection. As expected, both WSN and WSN ΔNS1 infected cells depleted from Aly/REF and UAP56 exhibited a significant M mRNA nuclear export defect (Fig. 6a,b) . Importantly, the nuclear speckle accumulation and splicing enhancement seen after Aly/REF and UAP56 knockdown in WSN ΔNS1 infected cells were reduced as compared to WSN infected cells (Fig. 6a-d and Supplementary Fig. 6 ). These results indicate that the splicing enhancement in Aly/REF and UAP56-deficient cells is dependent on nuclear speckle accumulation and reinforces the new role of NS1 described here as a driver of M mRNA to speckles to undergo splicing.
SON interacts with M1 mRNA and with factors required for M1 mRNA processing. We then investigated whether NS1 and the cellular proteins involved in M1 mRNA localization and splicing at nuclear speckles interact physically with SON, a major player in nuclear speckle assembly and alternative splicing 28, 29 . The major form of the SON protein is ∼263 kDa and runs as a broad band in SDS-polyacrylamide gel electrophoresis (PAGE) as it is probably post-translationally modified. Lower-molecular-weight forms of SON are predicted to be alternative spliced forms. We show that NS1-BP and hnRNP K interact with SON in noninfected or infected cells (Fig. 6e-g ). In addition, NS1 was pulleddown by SON antibody (Fig. 6g) . To this end, NS1 protein from influenza B virus has also been shown to interact with nuclear speckle domains 36 , further indicating the importance of this intranuclear body to the different strains of influenza virus. The NS1-BP and hnRNP K interactions with SON were detected by immunoprecipitations performed with either anti-NS1-BP antibody or anti-SON antibody in the presence or absence of RNA (Fig. 6e-g ). In uninfected cells, the interactions of SON with NS1-BP (Fig. 6e) or SON with hnRNP K (Fig. 6f ) were partially dependent on RNA. During infection, interactions of SON with hnRNP K and with NS1 also showed partial RNA dependence (Fig. 6g) . We then tested whether SON interacts directly with M1 mRNA. M1 mRNA was capped, 32 P-labelled and incubated with nuclear extracts. This was followed by ultraviolet treatment to crosslink RNA-protein interactions. RNA was digested and immunoprecipitations were performed with antibodies specific to SON, hnRNP U, Aly/REF and UAP56. hnRNP U was used as negative control based on our previous work, which demonstrated a direct interaction of hnRNP K with M1 mRNA and a lack of interaction with hnRNP U (ref. 23) . As shown in Fig. 6h , SON (∼263 kDa broad band) and its putative alternative spliced forms directly bound M1 mRNA, whereas hnRNP U, Aly/REF and UAP56 did not interact with M1 mRNA (Fig. 6h,i) . A lack of a direct interaction between Aly/REF or UAP56 with M1 mRNA is not surprising, as they probably require adaptor proteins to bind RNA. Thus, the interaction of SON with NS1, NS1-BP and hnRNP K, in addition to directly binding M1 mRNA, support the functional data that indicate M1 mRNA splicing at nuclear speckles.
Discussion
Taken together, our data indicate that M1 mRNA trafficking to nuclear speckles is dependent on the viral NS1 protein and the cellular NS1-BP protein. These findings support a model in which NS1 interacts with NS1-BP and directs the M1 mRNA to nuclear speckles during infection for hnRNP K-dependent splicing into from three independent experiments. **t-test P < 0.01. e-g, Cell extracts from uninfected or infected A549 cells treated with RNase inhibitor (RNasin) or with RNase A were subjected to immunoprecipitations with antibodies specific to NS1-BP or SON. Immunoprecipitates (bound) and unbound fractions were subjected to western blot using antibodies specific to the depicted proteins. h,i, SON binds directly to M1 mRNA. The entire M1 mRNA was radiolabelled uniformly at C residues, incubated with JSL1 nuclear extract under splicing conditions, crosslinked with 254 nm light and digested with RNase. The reaction was then either resolved by SDS-PAGE (25% total) or incubated in separate reactions with the antibodies indicated (IP: anti-). Total reaction or immunoprecipitated proteins were resolved by SDS-PAGE. j, Model for influenza virus M1 mRNA trafficking and splicing. Data shown in e-i are representative of three independent experiments.
M2 mRNA. It has been reported previously that NS1 can bind M1 mRNA and regulate M1 mRNA splicing 17 . Here, we have revealed a previously unknown function of NS1 as a mediator of M1 mRNA targeting to nuclear speckles and found that this promotes M1 to M2 mRNA splicing (Fig. 6j) . This may explain the unique M1 mRNA splicing kinetics in which M1 production predominates early in infection when NS1 synthesis is low, and then M1 to M2 mRNA splicing is probably enhanced by the high levels of NS1 at late stages of infection 37 . M2 protein has been shown to be cytotoxic to cells when expressed alone 38 , which suggests that M2 levels need to be tightly regulated during infection. Furthermore, M2 is critical for viral budding 39 , indicating that the timing of expression is probably important for the production of infectious viral particles, as premature synthesis could lead to defective particles.
The localization of M mRNA into speckles and M1 to M2 mRNA splicing also appears to be coupled to nuclear export. When M1 mRNA localization into intact speckles was impaired by infection with NS1-deficient virus or by depletion of NS1-BP or SON, we observed an accumulation of unspliced M1 mRNA in the nucleus. This effect may be related to previous reports suggesting that mRNA splicing can enhance mRNA nuclear export [40] [41] [42] [43] . Although our findings indicate that NS1 promotes viral M1 mRNA targeting to nuclear speckles for splicing into M2 mRNA, which is efficiently exported to the cytoplasm, NS1 is known to inhibit cellular mRNA export to prevent proper host gene expression and antiviral response [44] [45] [46] [47] , which happens later than the infection times used here. Together, these results indicate a differential role for NS1 in the nuclear export of viral versus host mRNAs, which may occur via different RNA-protein interactions. Another possibility is that the actions of NS1 on intranuclear trafficking of M mRNA are indirect, as NS1 is known to be a multifunctional protein involved in the regulation of gene expression at the RNA and protein levels 48 . Regarding M mRNA nuclear export, we showed that the cellular mRNA export factors Aly/REF and UAP56 are required for M1 and M2 mRNA export to the cytoplasm. In addition, knockdown of Aly/REF and UAP56 support compartmentalized M1 mRNA splicing at nuclear speckles. Depletion of these mRNA export factors enhanced the accumulation of M1 and M2 mRNAs at nuclear speckles and increased M1 to M2 mRNA splicing. Because M1 mRNA was blocked in the nucleus, the pool of M1 mRNA available for splicing is high and therefore may explain the increased levels of M1 mRNA splicing. Following meayamycin treatment of Aly/REF depleted cells, where nuclei were highly enriched with M1 mRNA, nuclear speckle accumulation of M1 mRNA was significantly reduced and a diffusive pattern was observed. This suggests that initial spliceosome assembly and specifically U2 snRNP deposition on M1 mRNA is required for M1 mRNA nuclear speckle accumulation and splicing, as meayamycin analogues were shown to bind the SF3b complex 35 . Importantly, enhancement of M1 mRNA splicing by Aly/REF and UAP56 knockdown was found to be dependent on entry into nuclear speckles, which was mediated by the viral NS1 protein. This finding underscores the importance of NS1 protein as a mediator of M1 mRNA targeting and splicing at nuclear speckles.
Active spliceosomes are present in nuclear speckles and appear to be involved in post-transcription splicing 6 . Here we found that M vRNAs that serve as templates for the generation of M1 mRNA were not present at nuclear speckles. This indicates that M1 mRNA is not generated at nuclear speckles but is post-transcriptionally spliced at this nuclear body. At steady state, active spliceosomes residing at nuclear speckles represent ∼9-25% of the entire active splicesome population 6 , as most cellular pre-mRNAs are spliced at transcribing genes 5, 49 and not inside nuclear speckles 1 . Thus, influenza virus subverts nuclear speckles to probably usurp splicing factors present in high concentration to promote efficient splicing and possibly inhibit host gene expression and antiviral response. Alternatively, the virus may use specific factors that are active at nuclear speckles for its M1 mRNA processing. The localization of M1 mRNA at nuclear speckles is consistent with a previous study showing differential intranuclear fractionation and splicing of M1 mRNA into M2 mRNA and mRNA 3 when the M segment was expressed using a SV40 recombinant virus as opposed to M1 mRNA splicing during influenza virus infection 50 . Thus, transcription of M1 mRNA by the specific influenza virus polymerase machinery and other viral factors may dictate M1 mRNA splicing at nuclear speckles. Finally, inhibition of this specific viral mRNA pathway through nuclear speckles may provide a strategy for the identification of antivirals.
Methods
Cell culture. Human lung adenocarcinoma epithelial cells (A549), Vero cells and MDCK cells were cultured in high-glucose DMEM (Gibco), 10% FBS (Atlas) and 100 units ml −1 Pen/Strep antibiotics. All cells were maintained at 37°C with 5% CO 2 . Cells were tested negative for mycoplasma. Cell lines were obtained and authenticated by ATCC. 23 . Influenza virus WSN ΔNS1 was generated as previously described 21 .
RNA interference and transfections. For imaging experiments, cells were grown on glass coverslips (Fisherbrand, Fisher Scientific) coated with 1 µl 0.1% gelatin (Sigma-Aldrich). The following day, siRNA oligos were transfected (see Supplementary Section 'siRNA oligos' for specifications of siRNA oligos) using RNAiMAX (Invitrogen) according to the manufacturer's instructions. Several siRNA oligos were tested for each mRNA target to exclude off-target effects. Plasmids (see Supplementary Section 'Plasmids') were transfected with Lipofectamine 2000 Transfection Reagent (Life Technologies) according to the manufacturer's protocol. After the indicated incubation time and/or infection, cells were either fixed for imaging or collected for RNA or protein purification.
Immunofluorescence. Cells grown on coverslips were fixed for 15 min in 4% paraformaldehyde (PFA, Electron Microscopy Sciences) and then permeabilized for 5 min in 0.5% Triton X-100. For detection of Aly/REF (see Supplementary Section 'Specifications of antibodies') at speckles, cells were permeabilized on ice with 0.05% Triton X-100 for 5 min before fixation. After blocking (20 min, 5% BSA), cells were immunostained for 1 h with a primary antibody (see Supplementary Section 'Specifications of antibodies'). Primary antibody was washed three times with PBS and then labelled with secondary antibody for 1 h. Coverslips were then washed twice with PBS, stained with 1 µg ml -1 Hoechst 33258 (Molecular Probes/ Life Technologies) for 10 min and briefly washed with PBS. Coverslips were mounted in ProLong Gold antifade reagent (Life Technologies).
FISH and immunofluorescence. Cells were fixed for 15 min in 4% PFA, incubated in ethanol for 12 h at 4°C, and then permeabilized for 5 min in 0.5% Triton X-100. For detection of Prp8 at speckles, cells were permeabilized on ice with 0.05% Triton X-100 for 5 min before fixation. Next, cells were briefly washed with PBS and immunostained for 1 h with a primary antibody diluted in inhibition buffer (see Supplementary Section 'Specifications of buffers'). Coverslips were briefly washed with 0.2% Triton X-100 and PBS. Wash buffer was added for 5 min. The wash buffer was then removed and FISH probe in hybridization buffer was added. Hybridization was carried at 37°C for 4 h. The probe was removed, and cells were washed with wash buffer for 30 min at 37°C and briefly washed with PBS. Cells were labelled with secondary antibody for 1 h. Coverslips were washed twice for 5 min in PBS, stained with 1 µg ml -1 Hoechst 33258 (Molecular Probes/Life Technologies) for 10 min and then briefly washed with PBS. Coverslips were mounted in ProLong Gold antifade reagent (Life Technologies). In situ hybridization alone was performed as described above without triton or antibody treatment.
Fluorescence microscopy and data analysis. Images were obtained with a Zeiss Axiovert 200 M automated microscope controlled by AxioVision software. Images were taken with a Zeiss ×60 Plan-APOCHROMAT lens (1.4 numerical aperture) and captured by a Zeiss AxioCam MRm camera. Multiple z planes were captured to collect signals from both the cytoplasm and the nuclear compartments. The z stack images were deconvolved with AutoQuant software. Pearson's correlation coefficients were analysed by Imaris (Bitplane) using the ImarisColoc tool. The Pearson's correlation coefficients were measured in the nucleus using a Hoechst channel for masking. Additionally, deconvolved images were analysed by Imaris (Bitplane) using the Spots tool for single RNA detection and quantification, and the Surfaces tool for segmentation and signal analysis within the cytoplasm, nucleus and nuclear speckles. The M mRNA cytoplasmic fluorescent signal presented in Fig. 1e,f was calculated based on volume analysis. Eleven, 0.3 µm z sections were taken for each three-dimensional image analysed. The signal was then deconvolved using AutoQuant software (three-dimensional deconvolution, ten iterations). The deconvolved images were then analysed using the Imaris spots tool, which detected individual spots (isolated spots could be resolved in the cytoplasm) and quantified the intensity sum of voxels within the detected spot volume. The distributions of detected single mRNA florescent intensities are unimodal, and the average intensity was calculated for further analysis of the bulk M mRNA signal at nuclear speckles.
RNA purification and RT-qPCR. Total RNA was isolated from A549 cells with TRIzol Reagent (Ambion) according to the manufacturer's instructions. RNA was reverse transcribed into cDNA by SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer's protocol. cDNA samples were amplified using SYBR green I (Roche) and specific primers (see Supplementary Section 'Primer specifications') in a LightCycler 480 quantitative real-time PCR (qPCR) system (Roche). In the case of RT-PCR, cDNA samples were amplified using Advantage 2 Polymerase Mix (Clontech) in a T100 Thermo Cycler (Bio-Rad), and products were analysed by agarose gel electrophoresis.
Meayamycin treatment. Cells were treated with either 100 nM meayamycin (in DMEM containing 0.1% dimethylsulfoxide (DMSO)) or 0.1% DMSO in DMEM (control) for 2 h and then infected with WSN at a multiplicity of infection (MOI) of 10. After 1 h, virus was removed and 100 nM meayamycin or 0.1% DMSO was added in infection medium for either 4 or 6 h. Cells were then either fixed for imaging or collected for RNA purification. In Supplementary Fig. 5 , cells were infected at an MOI of 10. After 1 h, virus was removed and 50 nM meayamycin or 0.1% DMSO was added to the infection medium for 3 h. The medium was then removed and infection medium containing either 50 nM meayamycin or 0.1% DMSO was added for an additional 4 h. Cells were then either fixed for imaging or collected for RNA purification.
Immunoprecipitation. Immunoprecipitation was performed as previously described 23 .
Ultraviolet crosslinking and RNA-protein interaction. The full-length M1 mRNA was transcribed from a linearized plasmid-based template by T7 polymerase using 32 P-CTP to 32 P-label the RNA throughout its length. Labelled M1 mRNA (10 nM) was incubated with 40% JSL1 nuclear extract in a total volume of 10.2 µl under splicing conditions, which contains (final concentration): 12 mM Tris-HCl, pH 7.5, 3.2 mM MgCl 2 , 1 mM ATP, 20 mM creatine phosphate (CP), 0.12 mM EDTA, 60 mM KCl, 1.3% polyvinyl alcohol (PVA), 250 ng yeast tRNA, 200 ng BSA and 12% glycerol. Reactions were incubated at 30°C for 20 min, crosslinked using ultraviolet light (254 nm) for 20 min on ice, and digested with RNaseT1 and RNase A for 20 min at 37°C. Reactions were resuspended in 2× SDS loading buffer, denatured for 5 min at 95°C, analysed under denaturing conditions on an SDS-PAGE gel (acrylamide/bis 37.5:1, Bio-Rad) and detected by autoradiography. Immunoprecipitation after crosslinking was carried out with antibodies against SON (GTX129778 GeneTex), UAP56 (SAB1307254 Sigma), AlyRef (A9979 Sigma) and hnRNP U (ab10297 abcam).
Statistical analysis. Statistical analyses were performed using the two-sample, two-tailed, t-test assuming equal variance. For statistical analysis of the M mRNA (M mRNA, M1 mRNA or M2 mRNA) imaging studies, the average intensity sum of the nuclear speckles (∼20-50 speckles per cell) within each cell was determined (9 to 29 cells were analysed, depending on the experimental conditions), as described in the figure legends. Therefore, a minimum of 200 speckles were analysed for each condition. For all imaging studies, a one-sample Kolmogorov-Smirnov test was conducted. A normal distribution can be assumed for all populations (P > 0.05). For the statistical analysis of M2/M1 mRNA ratios, three independent experiments were performed for each condition, and two-sample, two-tailed, t-tests were performed, assuming equal variance.
